Title : Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma.

Pub. Date : 2021 Sep 12

PMID : 34575229






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study aims to evaluate the relationship between human ribophorin II (RPN2) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for p-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC). TPF ribophorin II Homo sapiens
2 This study aims to evaluate the relationship between human ribophorin II (RPN2) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for p-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC). TPF ribophorin II Homo sapiens
3 Our study showed that RPN2 overexpression was significantly correlated with a poor response to induction chemotherapy with TPF. TPF ribophorin II Homo sapiens